60

Hubei Jumpcan Pharmaceutical Co LtdSHG 600566 Stock Report

Last reporting period 30 Sep, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

3.448

Middle

Exchange

XSHG - Shanghai Stock Exchange

600566.SS Stock Analysis

60

Attractive

Based on Eyestock quantitative analysis, 600566.SS`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

129/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

13.1 %

Undervalued

Market cap $B

3.448

Dividend yield

5.97 %

Shares outstanding

921.82 B

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs. The company is headquartered in Taizhou, Jiangsu and currently employs 6,632 full-time employees. The company went IPO on 2001-08-22. The firm's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The firm mainly distributes its products within domestic markets.

View Section: Eyestock Rating